rs6171

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The ENST00000647774.1(ENSG00000285947):​c.287-338A>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.408 in 1,610,114 control chromosomes in the GnomAD database, including 136,797 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.41 ( 12912 hom., cov: 32)
Exomes 𝑓: 0.41 ( 123885 hom. )

Consequence

ENSG00000285947
ENST00000647774.1 intron

Scores

2

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:3

Conservation

PhyloP100: -1.35

Publications

14 publications found
Variant links:
Genes affected
GH1 (HGNC:4261): (growth hormone 1) The protein encoded by this gene is a member of the somatotropin/prolactin family of hormones which play an important role in growth control. The gene, along with four other related genes, is located at the growth hormone locus on chromosome 17 where they are interspersed in the same transcriptional orientation; an arrangement which is thought to have evolved by a series of gene duplications. The five genes share a remarkably high degree of sequence identity. Alternative splicing generates additional isoforms of each of the five growth hormones, leading to further diversity and potential for specialization. This particular family member is expressed in the pituitary but not in placental tissue as is the case for the other four genes in the growth hormone locus. Mutations in or deletions of the gene lead to growth hormone deficiency and short stature. [provided by RefSeq, Jul 2008]
GH1 Gene-Disease associations (from GenCC):
  • isolated growth hormone deficiency type IA
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics, Orphanet
  • isolated growth hormone deficiency type II
    Inheritance: AD Classification: STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics, Orphanet
  • isolated growth hormone deficiency type IB
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
  • short stature due to growth hormone qualitative anomaly
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.65).
BP6
Variant 17-63918844-T-C is Benign according to our data. Variant chr17-63918844-T-C is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 369220.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.43 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
GH1NM_000515.5 linkc.-68A>G upstream_gene_variant ENST00000323322.10 NP_000506.2 P01241-1B1A4G6
GH1NM_022559.4 linkc.-68A>G upstream_gene_variant NP_072053.1 P01241-2B1A4G7
GH1NM_022560.4 linkc.-68A>G upstream_gene_variant NP_072054.1 P01241-5

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
ENSG00000285947ENST00000647774.1 linkc.287-338A>G intron_variant Intron 4 of 7 ENSP00000497443.1 A0A3B3ISS9
GH1ENST00000323322.10 linkc.-68A>G upstream_gene_variant 1 NM_000515.5 ENSP00000312673.5 P01241-1

Frequencies

GnomAD3 genomes
AF:
0.408
AC:
61570
AN:
150844
Hom.:
12901
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.431
Gnomad AMI
AF:
0.439
Gnomad AMR
AF:
0.327
Gnomad ASJ
AF:
0.469
Gnomad EAS
AF:
0.306
Gnomad SAS
AF:
0.276
Gnomad FIN
AF:
0.359
Gnomad MID
AF:
0.417
Gnomad NFE
AF:
0.434
Gnomad OTH
AF:
0.411
GnomAD4 exome
AF:
0.408
AC:
595258
AN:
1459152
Hom.:
123885
Cov.:
44
AF XY:
0.405
AC XY:
294324
AN XY:
725914
show subpopulations
African (AFR)
AF:
0.429
AC:
14188
AN:
33076
American (AMR)
AF:
0.270
AC:
12071
AN:
44634
Ashkenazi Jewish (ASJ)
AF:
0.472
AC:
12328
AN:
26120
East Asian (EAS)
AF:
0.293
AC:
11645
AN:
39684
South Asian (SAS)
AF:
0.297
AC:
25608
AN:
86182
European-Finnish (FIN)
AF:
0.356
AC:
18988
AN:
53398
Middle Eastern (MID)
AF:
0.425
AC:
2447
AN:
5754
European-Non Finnish (NFE)
AF:
0.426
AC:
473384
AN:
1110034
Other (OTH)
AF:
0.408
AC:
24599
AN:
60270
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.477
Heterozygous variant carriers
0
17746
35492
53238
70984
88730
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
14246
28492
42738
56984
71230
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.408
AC:
61619
AN:
150962
Hom.:
12912
Cov.:
32
AF XY:
0.399
AC XY:
29473
AN XY:
73802
show subpopulations
African (AFR)
AF:
0.431
AC:
17510
AN:
40630
American (AMR)
AF:
0.327
AC:
4974
AN:
15218
Ashkenazi Jewish (ASJ)
AF:
0.469
AC:
1625
AN:
3468
East Asian (EAS)
AF:
0.306
AC:
1581
AN:
5172
South Asian (SAS)
AF:
0.276
AC:
1319
AN:
4778
European-Finnish (FIN)
AF:
0.359
AC:
3802
AN:
10578
Middle Eastern (MID)
AF:
0.417
AC:
121
AN:
290
European-Non Finnish (NFE)
AF:
0.434
AC:
29423
AN:
67830
Other (OTH)
AF:
0.414
AC:
866
AN:
2092
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.495
Heterozygous variant carriers
0
1811
3622
5434
7245
9056
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
580
1160
1740
2320
2900
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.277
Hom.:
673
Bravo
AF:
0.405

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Nov 12, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is associated with the following publications: (PMID: 12655556) -

Isolated congenital growth hormone deficiency Benign:1
Jun 14, 2016
Illumina Laboratory Services, Illumina
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.65
CADD
Benign
0.62
DANN
Benign
0.90
PhyloP100
-1.3
PromoterAI
-0.015
Neutral
Mutation Taster
=156/144
polymorphism

Splicing

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs6171; hg19: chr17-61996204; COSMIC: COSV105177127; API